New Radiation Treatment Strategies for Early Stage Breast Cancer

  • Abram Recht
Part of the Cancer Treatment and Research book series (CTAR, volume 141)

The development of breast-conserving therapy (BCT) using whole-breast irradiation (WBI) to eradicate residual disease following nonablative resection of breast cancer was one of the great success stories of twentieth-century oncology. Approximately 70-80% of patients with stage I or II invasive breast cancers are estimated to be potential candidates on technical grounds for BCT.


Breast Cancer Clin Oncol Radiat Oncol Biol Phys Breast Irradiation Ipsilateral Breast Tumor Recurrence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Morrow, M., E. A. Strom, L. W. Bassett, et al. 2002. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 52:277–300.PubMedCrossRefGoogle Scholar
  2. 2.
    Tyldesley, S., F. Foroudi, L. Barbera, et al. 2003. The appropriate rate of breast conserving surgery: an evidence-based estimate. Clin Oncol 15:144–55.CrossRefGoogle Scholar
  3. 3.
    Cady, B., M. D. Stone, J. G. Schuler, et al. 1996. The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 131:301–08.PubMedGoogle Scholar
  4. 4.
    Fisher, B., J. Dignam, E. P. Mamounas, et al. 1996. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 14:1982–92.PubMedGoogle Scholar
  5. 5.
    Rutqvist, L. E., B. Cedermark, U. Glas, et al. 1992. Randomized trial of adjuvant tamoxifen in node negative postmenopausal breast cancer. Acta Oncol 31:265–70.PubMedCrossRefGoogle Scholar
  6. 6.
    Fisher, B., J. Dignam, J. Bryant, et al. 1996. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 88:1529–42.PubMedCrossRefGoogle Scholar
  7. 7.
    Fisher, B., J. Bryant, J. J. Dignam, et al. 2002. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141–49.PubMedCrossRefGoogle Scholar
  8. 8.
    Recht, A. 2007. Breast - Stages I-II. In: Gunderson LL, Tepper JE, eds. Clinical Radiation Oncology. 2nd ed. New York: Churchill Livingstone, 1475–502.Google Scholar
  9. 9.
    Recht, A. 2005. Lessons of studies of breast-conserving therapy with and without whole-breast irradiation for patient selection for partial-breast irradiation. Semin Radiat Oncol 15:123–32.PubMedCrossRefGoogle Scholar
  10. 10.
    Shapiro, C. L., A. Recht. 2001. Side effects of adjuvant therapy for breast cancer. N Engl J Med 344:1997–2008.PubMedCrossRefGoogle Scholar
  11. 11.
    Veronesim, U., E. Marubini, L. Mariani, et al. 2001. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12:997–1003.CrossRefGoogle Scholar
  12. 12.
    McCready, D.R., J. A. Chapman, W. M. Hanna, et al. 2000. Factors associated with local breast cancer recurrence after lumpectomy alone: postmenopausal patients. Ann Surg Oncol 7:562–67.PubMedCrossRefGoogle Scholar
  13. 13.
    Liljegren, G., L. Holmberg, J. Bergh, et al. 1999. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 17:2326–33.PubMedGoogle Scholar
  14. 14.
    Hughes, K. S., L. A. Schnaper, D. Berry, et al. 2004. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351:971–77.PubMedCrossRefGoogle Scholar
  15. 15.
    Hughes, K. S., L. A. Schnaper, D. Berry, et al. 2006. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer: a report of further follow-up (abstract 11). Breast Cancer Treat Res 100(suppl. 1):S8.Google Scholar
  16. 16.
    Fyles, A. W., D. R. McCready, L. A. Manchul, et al. 2004. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963–70.PubMedCrossRefGoogle Scholar
  17. 17.
    Fyles, A., L. Manchul, D. McCready, et al. 2006. Updated results of a randomized trial of tamoxifen with or without breast irradiation in women over 50 years of age with T1/2 N0 breast cancer (abstract 3). Radiother Oncol 80(suppl. 1):S1.CrossRefGoogle Scholar
  18. 18.
    Blamey, R. W., U. Chetty, D. George, et al. 2005. The BASO II trial of primary treatment of tumours of excellent prognosis: 2005 update (abstract O-100). EJC Suppl 3(1):32.Google Scholar
  19. 19.
    Winzer, K-J., R. Sauer, W. Sauerbrei, et al. 2004. Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 40:998–1005.PubMedCrossRefGoogle Scholar
  20. 20.
    Lee, S. H., M. A. Chung, D. Chelmow, et al. 2004. Avoidance of adjuvant radiotherapy in selected patients with invasive breast cancer. Ann Surg Oncol 11:316–21.PubMedCrossRefGoogle Scholar
  21. 21.
    Gruenberger, T., M. Gorlitzer, M. Mittlboeck, et al. 1998. Adjuvant radiotherapy has no benefit after primary breast cancer treatment in selected postmenopausal patients (abstract P60). Eur J Cancer 34(suppl. 1):S31.CrossRefGoogle Scholar
  22. 22.
    Lim, M., J. R. Bellon, R. Gelman, et al. 2006. A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer. Int J Radiat Oncol Biol Phys 65:1149–54.PubMedGoogle Scholar
  23. 23.
    Valassiadou, K., J. F. Robertson. 2002. Efficacy of breast conserving surgery without adjuvant radiotherapy for invasive breast cancer in the elderly (abstract P27). Eur J Surg Oncol 28:797–98.Google Scholar
  24. 24.
    Early Breast Cancer Trialists’ Collaborative Group. 2005. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–106.Google Scholar
  25. 25.
    Palda, V. A., H. A. Llewellyn-Thomas, R. G. Mackenzie, et al. 1997. Breast cancer patients’ attitudes about rationing postlumpectomy radiation therapy: applicability of trade-off methods to policy-making. J Clin Oncol 15:3192–200.PubMedGoogle Scholar
  26. 26.
    Hayman, J. A., D. L. Fairclough, J. R. Harris, et al. 1997. Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer. J Clin Oncol 15:1252–60.PubMedGoogle Scholar
  27. 27.
    Vicini, F. A., L. L. Kestin, N. S. Goldstein. 2004. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys 60:722–30.PubMedCrossRefGoogle Scholar
  28. 28.
    Morimoto, T., K. Okazaki, K. Komaki, et al. 1993. Cancerous residue in breast-conserving surgery. J Surg Oncol 52:71–76.PubMedCrossRefGoogle Scholar
  29. 29.
    Kuerer, H. M., T. B. Julian, E. A. Strom, et al. 2004. Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg 239:338–51.PubMedCrossRefGoogle Scholar
  30. 30.
    Arthur, D. W., F. A. Vicini. 2005. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 23:1726–35.PubMedCrossRefGoogle Scholar
  31. 31.
    King, T. A., J. S. Bolton, R. R. Kuske, et al. 2000. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for Tis, 1,2 breast cancer. Am J Surg 180:299–304.PubMedCrossRefGoogle Scholar
  32. 32.
    Vicini, F. A., L. Kestin, P. Chen, et al. 2003. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 95:1205–10.PubMedCrossRefGoogle Scholar
  33. 33.
    Polgár, C., T. Major, J. Fodor, et al. 2004. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: Seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60:1173–81.PubMedGoogle Scholar
  34. 34.
    Keisch, M., F. Vicini, R. R. Kuske, et al. 2003. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55:289–93.PubMedGoogle Scholar
  35. 35.
    Pignol, J. P., B. Keller, E. Rakovitch, et al. 2006. First report of a permanent breast 103Pd seed implant as adjuvant radiation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys 64:176–81.PubMedGoogle Scholar
  36. 36.
    Vaidya, J. S., J. S. Tobias, M. Baum, et al. 2004. Intraoperative radiotherapy for breast cancer. Lancet Oncol 5(3):165–73.PubMedCrossRefGoogle Scholar
  37. 37.
    Veronesi, U., G. Gatti, A. Luini, et al. 2003. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg 138:1253–56.PubMedCrossRefGoogle Scholar
  38. 38.
    Vicini, F. A., V. Remouchanps, M. Wallace, et al. 2003. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 57:1247–53.PubMedGoogle Scholar
  39. 39.
    Formenti, S. C., B. Rosenstein, K. A. Skinner, et al. 2002. T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients–pilot feasibility study. Radiology 222:171–78.PubMedCrossRefGoogle Scholar
  40. 40.
    Taghian, A. G., K. R. Kozak, K. P. Doppke, et al. 2006. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 64:1092–99.PubMedGoogle Scholar
  41. 41.
    Kozak, K. R., B. L. Smith, J. Adams, et al. 2006. Accelerated partial-breast irradiation using proton beams: initial clinical experience. Int J Radiat Oncol Biol Phys 66:691–98.PubMedGoogle Scholar
  42. 42.
    Vicini, F. A., J. V. Antonucci, M. Wallace, et al. 2007. Long-term efficacy and patterns of failure after accelerated partial breast irradiation: A molecular assay-based clonality evaluation. Int J Radiat Oncol Biol Phys: 68:341–46.PubMedGoogle Scholar
  43. 43.
    Perera, F., E. Yu, J. Engel, et al. 2003. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years’ minimum follow-up. Int J Radiat Oncol Biol Phys 57:1239–46.PubMedGoogle Scholar
  44. 44.
    Arthur, D. W., K. Winter, R. R. Kuske, et al. 2006. A phase II trial of brachytherapy alone following lumpectomy for select breast cancer” tumor control and survival outcomes of RTOG 95–17 (abstract 51). Int J Radiat Oncol Biol Phys 66(3 suppl.):S29–30.Google Scholar
  45. 45.
    Kuske, R. R., C. Boyer, J. S. Bolton, et al. 2004. Long-term results of the Ochsner Clinic prospective phase II breast brachytherapy trial (abstract 4068). Breast Cancer Res Treat 88(1 suppl.):S171.Google Scholar
  46. 46.
    Vicini, F. A., K. L. Baglan, L. L. Kestin, et al. 2001. Accelerated treatment of breast cancer. J Clin Oncol 19:1993–2001.PubMedGoogle Scholar
  47. 47.
    Chen, P. Y., F. A. Vicini, P. Benitez, et al. 2006. Long-term cosmetic results and toxicity after accelerated partial-breast irradiation: a method of radiation delivery by interstitial brachytherapy for the treatment of early-stage breast carcinoma. Cancer 106:991–99.PubMedCrossRefGoogle Scholar
  48. 48.
    Ribeiro, G. G., G. Dunn, R. Swindell, et al. 1990. Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. Clin Oncol 2:27–34.CrossRefGoogle Scholar
  49. 49.
    Ribeiro, G. G., B. Magee, R. Swindell, et al. 1993. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol 5:278–83.CrossRefGoogle Scholar
  50. 50.
    Magee, B., E. A. Young, R. Swindell. 1998. Patterns of breast relapse foloowing breast conserving surgery and radiotherapy (abstract). Br J Cancer 78(suppl. 2):24.Google Scholar
  51. 51.
    Dodwell, D. J., K. Dyker, J. Brown, et al. 2005. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol 17:618–22.CrossRefGoogle Scholar
  52. 52.
    Polgár, C., K. Lovey, T. Major, et al. 2006. Partial breast irradiation (PBI) versus whole breast irradiation (WBI) after breast conserving therapy for low-risk breast cancer patients: 5-year results of a randomized study (abstract 368). Radiother Oncol 81(suppl 1):S148.Google Scholar
  53. 53.
    Polgár, C., V. Strnad, T. Major. 2005. Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol 15:116–22.PubMedCrossRefGoogle Scholar
  54. 54.
    Coles, C., J. Yarnold. 2006. The IMPORT trials are launched (September 2006). Clin Oncol 18:587–90.CrossRefGoogle Scholar
  55. 55.
    Olivotto, I., T. Whelan, K. Vallis, et al. 2006. Initial results of a Canadian feasibility study of accelerated partial breast irradiation (APBI) using 3-D conformal radiation therapy (3D CRT) (abstract 53). Radiother Oncol 80(suppl. 1):S16.CrossRefGoogle Scholar
  56. 56.
    Lawenda, B. D., A. G. Taghian, L. A. Kachnic, et al. 2003. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 56:671–80.PubMedGoogle Scholar
  57. 57.
    Wazer, D. E., D. Lowther, T. Boyle, et al. 2001. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 50:107–11.PubMedGoogle Scholar
  58. 58.
    Vicini, F. A., P. D. Beitsch, C. A. Quiet, et al. 2005. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 104:1138–48.PubMedCrossRefGoogle Scholar
  59. 59.
    Wazer, D. E., S. Kaufman, L. Cuttino, et al. 2006. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys 64:489–95.PubMedGoogle Scholar
  60. 60.
    Kuske, R. R., K. Winter, D. W. Arthur, et al. 2006. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95–17. Int J Radiat Oncol Biol Phys 65:45–51.PubMedGoogle Scholar
  61. 61.
    Valdagni, R., M. Ciocca, L. Busana, et al. 1992. Beam modifying devices in the treatment of early breast cancer: 3-D stepped compensating technique. Radiother Oncol 23:192–95.PubMedCrossRefGoogle Scholar
  62. 62.
    Evans, P. M., E. M. Donovan, N. Fenton, et al. 1998. Practical implementation of compensators in breast radiotherapy. Radiother Oncol 49:255–65.PubMedCrossRefGoogle Scholar
  63. 63.
    Chang, S. X., K. M. Deschesne, T. J. Cullip, et al. 1999. A comparison of different intensity modulation treatment techniques for tangential breast irradiation. Int J Radiat Oncol Biol Phys 45:1305–14.PubMedCrossRefGoogle Scholar
  64. 64.
    Vicini, F. A., M. Sharpe, L. Kestin, et al. 2002. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 54:1336–44.PubMedCrossRefGoogle Scholar
  65. 65.
    Lo, Y. C., G. Yasuda, T. J. Fitzgerald, et al. 2000. Intensity modulation for breast treatment using static multi-leaf collimators. Int J Radiat Oncol Biol Phys 46:187–94.PubMedCrossRefGoogle Scholar
  66. 66.
    Guerrero, M., X. A. Li, M. A. Earl, et al. 2004. Simultaneous integrated boost for breast cancer using IMRT: a radiobiological and treatment planning study. Int J Radiat Oncol Biol Phys 59:1513–22.PubMedGoogle Scholar
  67. 67.
    Cho, B. C., C. W. Hurkmans, E. M. Damen, et al. 2002. Intensity modulated versus non-intensity modulated radiotherapy in the treatment of the left breast and upper internal mammary lymph node chain: a comparative planning study. Radiother Oncol 62:127–36.PubMedCrossRefGoogle Scholar
  68. 68.
    Krueger, E. A., B. A. Fraass, D. L. McShan, et al. 2003. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 56:1023–37.PubMedCrossRefGoogle Scholar
  69. 69.
    Lomax, A. J., L. Cella, D. Weber, et al. 2003. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 55:785–92.PubMedGoogle Scholar
  70. 70.
    Yarnold, J. R., E. Donovan, N. Bleackley, et al. 2002. Randomised trial of standard 2D radiotherapy (RT) versus 3D intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy (abstract 47). Radiother Oncol 64(suppl. 1):S15.Google Scholar
  71. 71.
    Pignol, J., I. Olivotto, E. Rakovitch, et al. 2006. Phase III randomized study of intensity modulated radiation therapy versus standard wedging technique for adjuvant breast radiotherapy (abstract plenary 1). Int J Radiat Oncol Biol Phys 66(3 suppl.):S1.Google Scholar
  72. 72.
    Mayo, C., Y. C. Lo, T. J. Fitzgerald, et al. 2004. Forward-planned, multiple-segment, tangential fields with concomitant boost in the treatment of breast cancer. Med Dosim 29:265–70.PubMedCrossRefGoogle Scholar
  73. 73.
    Recht, A. 2006. Which breast cancer patients should really worry about radiation-induced heart disease–and how much? J Clin Oncol 24:4059–61.PubMedCrossRefGoogle Scholar
  74. 74.
    Remouchamps, V. M., N. Letts, D. Yan, et al. 2003. Three-dimensional evaluation of intra- and interfraction immobilization of lung and chest wall using active breathing control: a reproducibility study with breast cancer patients. Int J Radiat Oncol Biol Phys 57:968–78.PubMedGoogle Scholar
  75. 75.
    Pedersen, A. N., S. Korreman, H. Nyström, et al. 2004. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother Oncol 72:53–60.PubMedCrossRefGoogle Scholar
  76. 76.
    Frazier, R. C., F. A. Vicini, M. B. Sharpe, et al. 2004. Impact of breathing motion on whole breast radiotherapy: a dosimetric analysis using active breathing control. Int J Radiat Oncol Biol Phys 58:1041–47.PubMedGoogle Scholar
  77. 77.
    Remouchamps, V. M., N. Letts, F. A. Vicini, et al. 2003. Initial clinical experience with moderate deep-inspiration breath hold using an active breathing control device in the treatment of patients with left-sided breast cancer using external beam radiation therapy. Int J Radiat Oncol Biol Phys 56:704–15.PubMedCrossRefGoogle Scholar
  78. 78.
    Fourquet, A., F. Campana, J-C. Rosenwald, et al. 1991. Breast irradiation in the lateral decubitus position: technique of the Institut Curie. Radiother Oncol 22:261–65.PubMedCrossRefGoogle Scholar
  79. 79.
    Griem, K. L., P. Fetherston, M. Kuznetsova, et al. 2003. Three-dimensional photon dosimetry: a comparison of treatment of the intact breast in the supine and prone position. Int J Radiat Oncol Biol Phys 57:891–99.PubMedGoogle Scholar
  80. 80.
    Parhar, P. K., C. Constantine, M. Rasca-Alamgir, et al. 2006. Preliminary results of NYU 05–181, a prospective trial to establish the individual optimal positioning from breast radiotherapy (abstract 1082). Int J Radiat Oncol Biol Phys 66(3 suppl.)(S177).Google Scholar
  81. 81.
    Nuyten, D. S., B. Kreike, A. A. Hart, et al. 2006. Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8:R62.PubMedCrossRefGoogle Scholar
  82. 82.
    Chang H. Y., D. S. Nuyten, J. B. Sneddon, et al. 2005. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 102:3738–43.PubMedCrossRefGoogle Scholar
  83. 83.
    Bentzen, S. M., M. Overgaard, J. Overgaard. 1993. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur J Cancer 29A:1373–76.PubMedCrossRefGoogle Scholar
  84. 84.
    Iannuzzi, C. M., D. P. Atencio, S. Green, et al. 2002. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 52:606–13.PubMedCrossRefGoogle Scholar
  85. 85.
    Andreassen, C. N., J. Overgaard, J. Alsner, et al. 2006. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 64:776–83.PubMedGoogle Scholar
  86. 86.
    Andreassen, C. N., J. Alsner, M. Overgaard, et al. 2006. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM–a study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol 82:577–86.PubMedCrossRefGoogle Scholar
  87. 87.
    Yarnold, J., A. Ashton, J. Bliss, et al. 2005. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 75:9–17.PubMedCrossRefGoogle Scholar
  88. 88.
    Rose, C. M., A. Recht. 2003. Accelerated partial breast irradiation (APBI): let’s give it a good test (Editorial). Int J Radiat Oncol Biol Phys 57:1217–18.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Abram Recht
    • 1
  1. 1.Department of Radiation OncologyBeth Israel Deaconess Medical CenterBostonUSA

Personalised recommendations